Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cassiman

Showing results (161-170 of 201) with videos related to

Pageof 21
Sort By:
The Lancet. Gastroenterology & Hepatology|October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trialMichael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
Nature Communications|June 13, 2019
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cellsKim R Kampen, Laura Fancello, Tiziana Girardi, et al.
JHEP Reports : Innovation in Hepatology|August 14, 2024
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targetsPeter Ott, Thomas Sandahl, Aftab Ala, et al.
Leukemia|June 23, 2018
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.
Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON studyMarjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
Circulation|June 9, 2017
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)Marjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 27, 2020
De novo loss-of-function variants in X-linked MED12 are associated with Hardikar syndrome in femalesDong Li, Alanna Strong, Kaitlyn M Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2019
Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride ContentNynke Simons, François-Guillaume Debray, Nicolaas C Schaper, et al.
Circulation|February 13, 2018
Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"D Meeike Kusters, Marjet J A M Braamskamp, Gisle Langslet, et al.
Leukemia|March 10, 2019
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.
Pageof 21

Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
The Lancet. Gastroenterology & Hepatology|October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trialMichael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
Nature Communications|June 13, 2019
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cellsKim R Kampen, Laura Fancello, Tiziana Girardi, et al.
JHEP Reports : Innovation in Hepatology|August 14, 2024
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targetsPeter Ott, Thomas Sandahl, Aftab Ala, et al.
Leukemia|June 23, 2018
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.
Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON studyMarjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
Circulation|June 9, 2017
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)Marjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 27, 2020
De novo loss-of-function variants in X-linked MED12 are associated with Hardikar syndrome in femalesDong Li, Alanna Strong, Kaitlyn M Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2019
Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride ContentNynke Simons, François-Guillaume Debray, Nicolaas C Schaper, et al.
Circulation|February 13, 2018
Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"D Meeike Kusters, Marjet J A M Braamskamp, Gisle Langslet, et al.
Leukemia|March 10, 2019
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALLKim R Kampen, Sergey O Sulima, Benno Verbelen, et al.
Pageof 21